Profitability
Weight: 15%
F
0
- 5yr Avg ROIC -59.8%
- Operating Margin Trend -11.49 pp/yr
ABUS
Arbutus Biopharma Corporation
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 23.5 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -84.1%
- 5yr Share-Count CAGR 15.9%
Growth Quality
Weight: 35%
C-
49
- 5yr Revenue CAGR 6.4%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -505.7%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
F
25
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -278.88x
- Altman Z-Score 28.59
Stability
Weight: 5%
B+
77
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 5
- Negative-Revenue Years (5) 2/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 new buy; 1 trimmed.
- Holders
- 2 +1
- Avg Δ position
- -38.2%
- New buys
- 1
- Full exits
- 0
- Greenblatt new
- Cooperman decreased -38%